OXTELLAR XR: payments to doctors
Payments that named OXTELLAR XR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $675K
- Providers
- 4,676
- Transactions
- 26,182
- Average per transaction
- $26
The per-transaction average — $26 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,676 providers the average total is $144, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $674,715 | 100.0% |